Yoga for Idiopathic Pulmonary Fibrosis
(YES-IPF Trial)
Trial Summary
What is the purpose of this trial?
This study will evaluate whether regular yoga exercises designed specifically for patients with Idiopathic Pulmonary Fibrosis is associated with any change in quality of life. Half of the participants will be randomized to yoga, half to usual care. Yoga was conducted live, virtually, in the setting of the COVID Pandemic.
Research Team
Bridget F Collins, MD
Principal Investigator
University of Washington, Center for Interstitial Lung Diseases
Ganesh Raghu, MD
Principal Investigator
University of Washington, Center for Interstitial Lung Diseases
Eligibility Criteria
This trial is for adults over 18 with Idiopathic Pulmonary Fibrosis who can give informed consent and are followed at the University of Washington Medical Center's Center for Interstitial Lung Disease. Details on who cannot participate are not provided.Inclusion Criteria
Treatment Details
Interventions
- Yoga (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
Dr. Timothy H. Dellit
University of Washington
Chief Executive Officer since 2023
MD from University of Washington
Dr. Anneliese Schleyer
University of Washington
Chief Medical Officer since 2023
MD, MHA